Thursday November 21, 2024

|Subscribe
|Contribute
|About
|Access Your Account
|Register
|Login

|Home
|Issue Archive
- |Featured Reports
- |eBooks
|BioProcess Insider
|Multimedia
- |BPI White Papers
- |Webinars
- |Posters
|BioProcess International Events
- |BioProcess International US West
- |BioProcess International Europe
|BioProcess International Academy
|Events

Covering the whole development process for the global biotechnology industry

Upstream
Processing
Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
Downstream
Processing
Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
Manufacturing
Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
Analytical
Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
Business
Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.

From Cell Line Optimization to Aseptic Filling: Cooperative Partnering for Every Phase of Clinical Trials Materials Development and Production

View PDF

by BPI Contributor Saturday, July 1, 2006 9:00 am

Categories: 2006, July 2006

View PDF

← Older Post Newer Post →

Editor’s Choice

BioProcess Insider
Quell and Cellistic partner to develop cell therapy platform
BioProcess Insider
Shingrix sales bounce back post-pandemic for GSK
Sponsored Content
Product Quality in Focus
BioProcess Insider
Danaher and Sartorius: COVID just one variable affecting bioprocess growth
BioProcess Insider
Thermo Fisher opens $44m single-use Utah plant
Sponsored Content
The Critical Role of Predictive Bioreactor Characterization in Pharmaceutical Process-based Upscaling

Recent Tweets

Great panel discussion about the security of supply chains at the BPI Theatre #BPIWest https://t.co/rMFdNpHjhM 2 years ago
We’re at #BPIWEST, 2023! 2 years ago
What a great event #cphi2022 - see you in Barcelona next year! 2 years ago
We’re here & ready for the second day at #CPHI in Frankfurt! 2 years ago

Follow @bioproinsider

Explore Topics

Upstream Processing
Downstream Processing
Manufacturing
Analytical
Business

Publication

Issue Archive
Featured Reports
eBooks
Subscribe

BioProcessIntl.com

White Papers
Posters
Webinars
BPI Theater
Awards
Register
Login
Access Your Account

Keep up with BPI

Email Newsletters
Events
BioProcess Insider
Twitter
LinkedIn

About BPI

Who We Are
Editorial Advisors
Author Guidelines
Advertising/Media Kit
List Rental/Reprints
Contact Us
Careers

twitter linkedin

Site Map|Contact

©2024 BioProcess International All Rights reserved

Home
Issue Archive
▼
- Featured Reports
- eBooks
BioProcess Insider
Multimedia
▼
BioProcess International Events
▼
- BioProcess International US West
- BioProcess International Europe
BioProcess International Academy
Events